Robin Mogg
Overview
Explore the profile of Robin Mogg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
3513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waikar S, Mogg R, Baker A, Frendl G, Topper M, Adler S, et al.
Clin Pharmacol Ther
. 2025 Jan;
PMID: 39754474
Two observational studies were conducted to support an initiative to qualify translational kidney safety biomarkers as clinical drug development tools that identify tubular injury prior to changes in estimated glomerular...
2.
Stevens G, Dolley S, Mogg R, Connor J
Contemp Clin Trials Commun
. 2023 Jun;
34:101100.
PMID: 37388218
A number of principal investigators may have limited access to biostatisticians, a lack of biostatistical training, or no requirement to complete a timely statistical analysis plan (SAP). SAPs completed early...
3.
Pfister D, Haddad R, Worden F, Weiss J, Mehra R, Chow L, et al.
Cancer Med
. 2022 Dec;
12(6):6603-6614.
PMID: 36479637
Background: We performed an integrated biomarker evaluation in pembrolizumab-treated patients with R/M HNSCC enrolled in KEYNOTE-012 or KEYNOTE-055. The relationship between biomarkers and HPV status was explored. Methods: We evaluated...
4.
Miner M, Hatherill M, Mave V, Gray G, Nachman S, Read S, et al.
Lancet HIV
. 2022 Oct;
9(11):e791-e800.
PMID: 36240834
New tuberculosis vaccine candidates that are in the development pipeline need to be studied in people with HIV, who are at high risk of acquiring Mycobacterium tuberculosis infection and tuberculosis...
5.
Garcia-Basteiro A, White R, Tait D, Schmidt A, Rangaka M, Quaife M, et al.
Eur Respir Rev
. 2022 Jun;
31(164).
PMID: 35675923
Tuberculosis (TB) remains a leading infectious cause of death worldwide and the coronavirus disease 2019 pandemic has negatively impacted the global TB burden of disease indicators. If the targets of...
6.
Haddad R, Seiwert T, Chow L, Gupta S, Weiss J, Gluck I, et al.
J Immunother Cancer
. 2022 Feb;
10(2).
PMID: 35217573
Background: To characterize genomic determinants of response to pembrolizumab in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) in the KEYNOTE-012 study. Methods: Associations between biomarkers (tumor mutational burden...
7.
Ananworanich J, Mogg R, Dunne M, Bassyouni M, David C, Gonzalez E, et al.
Clin Infect Dis
. 2021 Sep;
75(1):e473-e481.
PMID: 34523673
Background: Severe acute respiratory syndrome coronavirus 2 infection may be associated with a prothrombotic state, predisposing patients for a progressive disease course. We investigated whether rivaroxaban, a direct oral anticoagulant...
8.
Matthews R, Ankrom W, Friedman E, Jackson Rudd D, Liu Y, Mogg R, et al.
Clin Transl Sci
. 2021 Aug;
14(5):1935-1944.
PMID: 34463432
Islatravir (MK-8591) is a nucleoside analogue in development for the treatment and prevention of HIV-1. Two phase 1 trials were conducted during initial evaluation of islatravir: rising single doses (Study...
9.
Hendrix S, Mogg R, Wang S, Chakravarty A, Romero K, Dickson S, et al.
Biomark Med
. 2021 May;
15(9):669-684.
PMID: 34037457
Qualification of a biomarker for use in a medical product development program requires a statistical strategy that aligns available evidence with the proposed context of use (COU), identifies any data...
10.
Park J, Mogg R, Smith G, Nakimuli-Mpungu E, Jehan F, Rayner C, et al.
Lancet Glob Health
. 2021 Apr;
9(5):e711-e720.
PMID: 33865476
COVID-19 has had negative repercussions on the entire global population. Despite there being a common goal that should have unified resources and efforts, there have been an overwhelmingly large number...